HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MoCRA Check-In: EAS Consulting's John Bailey On Proposed Cosmetics Office Move

Executive Summary

John Bailey, independent advisor for colors and cosmetics at EAS Consulting Group and former director of the US FDA's cosmetics office, is checking in with HBW Insight periodically in 2023 to offer his views on developments under the Modernization of Cosmetic Regulations Act of 2022. Here he discusses the FDA's plan to move cosmetics regulation out of CFSAN and into the Office of the Chief Scientist.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153468

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel